Seminars in Fetal & Neonatal Medicine

Papers
(The TQCC of Seminars in Fetal & Neonatal Medicine is 7. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Using rising tides to lift all boats: Equity-focused quality improvement as a tool to reduce neonatal health disparities53
Neuroimaging in the term newborn with neonatal encephalopathy48
Neonatal encephalopathy: Focus on epidemiology and underexplored aspects of etiology46
Neonatal encephalopathy: Etiologies other than hypoxic-ischemic encephalopathy30
Pharmacokinetics, pharmacodynamics and metabolism of caffeine in newborns29
Update on mechanisms of the pathophysiology of neonatal encephalopathy28
Therapies for neonatal encephalopathy: Targeting the latent, secondary and tertiary phases of evolving brain injury26
Diagnosis and management of pulmonary hypertension in infants with bronchopulmonary dysplasia24
Need for more evidence in the prevention and management of perinatal asphyxia and neonatal encephalopathy in low and middle-income countries: A call for action23
Unanswered questions regarding therapeutic hypothermia for neonates with neonatal encephalopathy23
Caffeine for preterm infants: Fixed standard dose, adjustments for age or high dose?21
Application and potential of artificial intelligence in neonatal medicine20
Neurological and developmental outcomes following neonatal encephalopathy treated with therapeutic hypothermia20
Supporting families in their child's journey with neonatal encephalopathy and therapeutic hypothermia19
Hemodynamic optimization for neonates with neonatal encephalopathy caused by a hypoxic ischemic event: Physiological and therapeutic considerations18
Placental contribution to neonatal encephalopathy17
Management of comfort and sedation in neonates with neonatal encephalopathy treated with therapeutic hypothermia17
A systematic review of reports of quality improvement for bronchopulmonary dysplasia17
LISA/MIST: Complex clinical problems almost never have easy solutions17
Respiratory support of infants born at 22–24 weeks of gestational age16
Infection prevention for extremely low birth weight infants in the NICU15
Inter-center variability in neonatal outcomes of preterm infants: A longitudinal evaluation of 298 neonatal units in 11 countries15
Bedside and laboratory neuromonitoring in neonatal encephalopathy15
Diagnosis & management of pulmonary hypertension in congenital diaphragmatic hernia14
The use of data in resource limited settings to improve quality of care14
Proposing a care practice bundle for neonatal encephalopathy during therapeutic hypothermia14
Pulmonary hypertension and oxidative stress: Where is the link?14
Pulmonary hypertension in the newborn- etiology and pathogenesis13
Nutrition and management of glycemia in neonates with neonatal encephalopathy treated with hypothermia13
Feeding considerations for infants with craniofacial malformations12
Pregnancy and Severe ARDS with COVID-19: Epidemiology, Diagnosis, Outcomes and Treatment12
Evidence and practical aspects of treatment with the Tübingen palatal plate12
Management of seizures in neonates with neonatal encephalopathy treated with hypothermia12
When to say no to inhaled nitric oxide in neonates?12
Cesarean delivery in low- and middle-income countries: A review of quality of care metrics and targets for improvement11
Fluid management, electrolytes imbalance and renal management in neonates with neonatal encephalopathy treated with hypothermia11
Maternal and neonatal outcomes following SARS-CoV-2 infection11
Perinatal asphyxia from the obstetric standpoint11
National and international guidelines for neonatal caffeine use: Are they evidenced-based?11
Delayed cord clamping in healthy term infants: More harm or good?10
The role of bedside functional echocardiography in the assessment and management of pulmonary hypertension10
Pulmonary vasodilator strategies in neonates with acute hypoxemic respiratory failure and pulmonary hypertension10
Patent ductus arteriosus management and the drift towards therapeutic nihilism – What is the evidence?10
Is caffeine available and affordable in low and middle-income countries? A survey in sub-Saharan Africa9
Transmission of SARS-CoV-2 from mother to fetus or neonate: What to know and what to do?9
Hemodynamic support of the micropreemie: Should hydrocortisone never be left out?9
Advantages and disadvantages of mandibular distraction in Robin sequence9
Closing the evidence to practice gap in neonatal transfusion medicine9
Early developmental screening and intervention for high-risk neonates - From research to clinical benefits9
Can we back off using antibiotics in the NICU?8
Challenges in respiratory management during therapeutic hypothermia for neonatal encephalopathy8
Management of cardiac dysfunction in neonates with pulmonary hypertension and the role of the ductus arteriosus8
Harnessing mobile technology to deliver evidence-based maternal-infant care8
Recovery of the brain after intraventricular hemorrhage8
Cannulation and decannulation techniques for neonatal ECMO8
Optimizing initial neonatal resuscitation to reduce neonatal encephalopathy around the world8
Milestones for clinical translation of the artificial placenta8
Escaping the Finnegan – Is it time?8
Impact of perinatal COVID on fetal and neonatal brain and neurodevelopmental outcomes8
Tissue engineering: Relevance to neonatal congenital heart disease8
Neurodevelopmental outcomes after neonatal caffeine therapy7
Prenatal management of congenital diaphragmatic hernia7
Cooling in mild encephalopathy: Costs and perils of therapeutic creep7
Towards personalized therapies for genetic disorders of surfactant dysfunction7
Oxygen saturation (SpO2) targeting for newborn infants at delivery: Are we reaching for an impossible unknown?7
When to start and stop caffeine and why respiratory status matters7
Personalized support of parents of extremely preterm infants before, during and after birth7
Multisystem inflammatory syndrome in neonates (MIS-N) associated with perinatal SARS CoV-2 infection: Does it exist?7
0.21184206008911